Glimepiride & Metformin Hydrochloride Prolonged Release , . . . q

Glimepiride & Metformin Hydrochloride Prolonged Release

GLIMITERIS M1 

1. • Glimepiride:

     • Glimepiride belongs to a class of medications called sulfonylureas, which work by stimulating the pancreas to release insulin. Insulin is a hormone that helps control blood sugar levels by facilitating the uptake of glucose into cells for energy production.
     • Glimepiride is typically taken orally once daily with breakfast or the first main meal of the day. The dosage is individualized based on blood sugar levels and response to treatment.
     • Common side effects of glimepiride may include hypoglycemia (low blood sugar), weight gain, gastrointestinal symptoms such as nausea or diarrhea, and allergic skin reactions.

   • Metformin Hydrochloride Prolonged Release:

     • Metformin is a biguanide medication that works primarily by reducing the production of glucose in the liver and improving insulin sensitivity in peripheral tissues such as muscle and fat. It also helps to decrease the absorption of glucose from the intestines and may promote weight loss.
     • Metformin hydrochloride prolonged-release formulations provide a controlled release of the medication over an extended period, allowing for once-daily dosing and potentially reduced gastrointestinal side effects.